Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Comprehensive Loss

v3.3.1.900
Consolidated Statements of Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Operating costs and expenses:    
Research and development $ (3,434,016) $ (6,323,896)
General and administrative (6,388,000) (6,600,870)
Loss from operations (9,822,016) (12,924,766)
Other income (expense):    
Change in fair value of derviative liability (2,125,117) 0
Loss on disposal of subsidiaries 0 (1,069,675)
Other expense (295,033) (326,916)
Interest income 1,694 18,959
Interest expense (266,999) (4,706)
Total other income (expense) (2,685,455) (1,382,338)
Net loss (12,507,471) (14,307,104)
Other comprehensive income (loss)    
Other comprehensive loss from foreign currency translation adjustment (321,942) (324,578)
Total comprehensive loss $ (12,829,413) $ (14,631,682)
Net loss per share of common stock, basic and diluted $ (.09) $ (.11)
Weighted-average shares of common stock outstanding, basic and diluted 140,397,488 135,896,022